Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 3
1993 5
1994 3
1995 10
1996 5
1997 4
1998 9
1999 4
2000 7
2001 5
2002 5
2003 6
2004 8
2005 8
2006 6
2007 7
2008 3
2009 3
2010 4
2011 3
2012 2
2013 4
2014 8
2015 11
2016 5
2017 5
2018 7
2019 14
2020 8
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.
Rothschild SI, Zippelius A, Eboulet EI, Savic Prince S, Betticher D, Bettini A, Früh M, Joerger M, Lardinois D, Gelpke H, Mauti LA, Britschgi C, Weder W, Peters S, Mark M, Cathomas R, Ochsenbein AF, Janthur WD, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Godar G, Rusterholz C, Gonzalez M, Pless M; Swiss Group for Clinical Cancer Research (SAKK). Rothschild SI, et al. Among authors: betticher d. J Clin Oncol. 2021 Sep 10;39(26):2872-2880. doi: 10.1200/JCO.21.00276. Epub 2021 Jul 12. J Clin Oncol. 2021. PMID: 34251873 Free article. Clinical Trial.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
[Immunotherapy: also in elderly patients ?].
Rhyner Agocs G, Dougoud-Chauvin V, Betticher D. Rhyner Agocs G, et al. Among authors: betticher d. Rev Med Suisse. 2019 Aug 28;15(660):1512-1515. Rev Med Suisse. 2019. PMID: 31496176 Review. French.
Melanoma: chemotherapy.
Lee SM, Betticher DC, Thatcher N. Lee SM, et al. Among authors: betticher dc. Br Med Bull. 1995 Jul;51(3):609-30. doi: 10.1093/oxfordjournals.bmb.a072982. Br Med Bull. 1995. PMID: 7552084 Review.
Swiss Delphi study on iron deficiency.
Nowak A, Angelillo-Scherrer A, Betticher D, Dickenmann M, Guessous I, Juillerat P, Korte W, Neuner-Jehle S, Pfister O, Surbek D, Battegay E, Steurer J. Nowak A, et al. Among authors: betticher d. Swiss Med Wkly. 2019 Jul 3;149:w20097. doi: 10.4414/smw.2019.20097. eCollection 2019 Jul 1. Swiss Med Wkly. 2019. PMID: 31269223 Free article.
[Fribourg to zenith?].
Hayoz D, Betticher D. Hayoz D, et al. Among authors: betticher d. Rev Med Suisse. 2010 Nov 17;6(271):2163-4. Rev Med Suisse. 2010. PMID: 21155289 French. No abstract available.
170 results